Jamieson Wellness Price Target Raised to $36 at TD Ahead of Q2 Results

TD Securities raised its price target on Jamieson Wellness Inc. (JWEL.TO) to $36 from $32 on Thursday.Analyst Derek J. Lessard maintained a Buy rating on shares of the Canadian health products

MT NewswiresJul 18 09:27 ET

Stifel Nicolaus Reaffirms Their Buy Rating on Jamieson Wellness Inc (JWEL)

TipRanksJul 2 07:45 ET

With 46% Stake, Jamieson Wellness Inc. (TSE:JWEL) Seems to Have Captured Institutional Investors' Interest

Yahoo FinanceJun 11 14:51 ET

BMO Says Stage Set to Drive Towards Jamieson Wellness >$1 Billion Revenue Target

BMO hosted Jamieson Wellness senior management for meetings in Europe and came away with "greater appreciation" for Jamieson's ability to execute on its long-term growth opportunities to drive towards

MT NewswiresJun 3 14:47 ET

Why It Might Not Make Sense To Buy Jamieson Wellness Inc. (TSE:JWEL) For Its Upcoming Dividend

Yahoo FinanceMay 26 08:15 ET

Jamieson Wellness Inc. Announces Voting Results From 2024 Annual Meeting of Shareholders

TORONTO, May 23, 2024 (GLOBE NEWSWIRE) -- Jamieson Wellness Inc. ("Jamieson Wellness" or the "Company") (TSX:JWEL) announced today that each of the nominee directors listed in the management information circular of the

GlobeNewswireMay 23 19:21 ET